Does a risky outcome of antenatal screening test indicate oxidative stress?

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 27, Issue 10, 2014, Pages 1033-1037

  Aksin, Mahmut ^a   Incebiyik, Adnan ^a   Vural, Mehmet ^a   Gul Hilali, Nese ^a   Camuzcuoglu, Aysun ^a   Camuzcuoglu, Hakan ^a   Aksoy, Nurten ^a  

^a HARRAN UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Amniocentesis; Anxiety; Prenatal screening; Total antioxidant status

Indexed keywords

ADULT; ADVERSE OUTCOME; AGING; AMNIOCENTESIS; AMNION FLUID; ANEUPLOIDY; ARTICLE; BIOCHEMISTRY; CHEMICAL PARAMETERS; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FETUS; GENETIC SCREENING; HIGH RISK PREGNANCY; HUMAN; MATERNAL AGE; MATERNAL BLOOD; OUTCOME ASSESSMENT; OXIDATIVE STRESS; OXIDATIVE STRESS INDEX; PATIENT COUNSELING; PREGNANCY OUTCOME; PREGNANT WOMAN; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SCORING SYSTEM; SECOND TRIMESTER PREGNANCY; TOTAL ANTIOXIDANT STATUS; TOTAL OXIDANT STATUS; CLINICAL TRIAL; MATERNAL SERUM SCREENING TEST; METABOLISM; PREGNANCY; RISK FACTOR;

ANTIOXIDANT; BIOLOGICAL MARKER; OXIDIZING AGENT;

ADULT; AMNIOCENTESIS; AMNIOTIC FLUID; ANTIOXIDANTS; BIOLOGICAL MARKERS; FEMALE; HUMANS; MATERNAL SERUM SCREENING TESTS; OXIDANTS; OXIDATIVE STRESS; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 84902132157     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2013.847421     Document Type: Article

References (21)

1. Wan X, Wen J, Song X, et al. The analysis of second-trimester triple screening for Down syndrome in Chinese normal singleton pregnancies. Scand J Clin Lab Invest 2012;72:642-7.
2. Chitayat D, Langlois S, Wilson RD. Prenatal screening for foetal aneuploidy in singleton pregnancies. J Obstet Gynecol Can 2011; 33:736-50.
3. Gupta P, Narang M, Banerjee BD, Basu S. Oxidative stress in term small for gestational age neonates born to undernourished mothers: a case-control study. BMC Pediatr 2004;4:14.
4. Ates M, Koksal MH, Celayir MF, Baykan A. Scanlarda intestinal derin iskemi-reperfuzyon modelinde ginkgo biloba ekstresinin [EGb761] profilaksi ve tedavide kullanmnn mortalite uzerine etkisi. Dicle Med J 2010;37:199-203.
5. Burlingame JM, Esfandiari N, Sharma RK, et al. Total antioksidant capacity and reactive oxygen species in amniotic fluid. Obstet Gynecol 2003;101:756-61.
6. Vural M, Camuzcuoglu H, Toy H, Aksoy N. Amniotic fluid prolidase activity and oxidative status in neural tube defects. Fetal Diagn Ther 2010;28:34-9.
7. Pratico D, Iuliano L, Amerio G. Down's syndrome is associated with increased 812-iso-iPF2alpha-VI levels: evidence for enhanced lipid peroxidation in vivo. Ann Neurol 2000;48:795-8.
8. Perrone S, Longini M, Bellieni CV, et al. Early oxidative stress in amniotic fluid of pregnancies with Down syndrome. Clin Biochem 2007;40:177-80.
9. Erel O. A novel automated direct measurement method for total antioxidantcapacity using a new generation, more stable ABTS radical cation. Clin Biochem 2004;37:277-85.
10. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005;38:1103-11.
11. Bolukbas C, Bolukbas FF, Horoz M, et al. Increased oxidative stress associated with the severity of the liver disease in various forms of hepatitis B virus infection. BMC Infect Dis 2005; 5:95.
12. Gupta S, Agarwal A, Banerjee J, Alvarez JG. The role of oxidative stress in spontaneous abortion and recurrent pregnancy loss: a systematic review. Obstet Gynecol Surv 2007;62:335-47.
13. Mihu D, Sabau L, Costin N, et al. Implications of maternal systemic oxidative stres in normal pregnancy and in pregnancy comlicated by preeclampsia. J Matern Fetal Neonatal Med 2012;7: 944-51.
14. Toy H, Camuzcuoglu H, Arioz DT, et al. Serum prolidase activity and oxidative stress markers in pregnancies with intrauterine growth restricted infants. J Obstet Gynaecol Res 2009;35:1047-53.
15. Cederberg J, Basu S, Eriksson UJ. Increased rate of lipid peroxidation and protein carbonylation in experimental diabetic pregnancy. Diabetologia 2001;44:766-74.
16. Ornoy A. Embryonic oxidative stress as a mechanism of teratogenesis with special emphasis on diabetic embryopathy. Reprod Toxicol 2007;27:31-41.
17. Felicity N, Berk M, Dean O, Bush AI. Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuropsychopharmacol 2008;11:851-76.
18. Hovatta I, Tennant RS, Helton R, et al. Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice. Nature 2005; 438:662-6.
19. Buyukhatipoglu H, Kirhan I, Vural M, et al. Oxidative Stress Increased in Healthcare Workers working 24-hour On-call Shifts. Am J Med Sci 2010;340:462-7.
20. Torun AN, Vural M, Cece H, et al. Paraoxonase-1 is not affected in polycystic ovary syndrome without metabolic syndrome and insulin resistance, but oxidative stress is altered. Gynecol Endocrinol 2011; 27:988-92.
21. Demirkol A, Uludag M, Soran N, et al. Total oxidative stres and antioxidant status in patients with carpal tunnel syndrome. Redox Rep 2012;17:234-8.